Infographic | September 9, 2022

Lessons Learned For Better Planning Of Decentralized Clinical Trials

GettyImages-872676342 technology

Due to the COVID-19 pandemic and subsequent restriction of physical access to clinical trial sites around the world, clinical trials have quickly pivoted to embracing virtual components. Even as we navigate out of the pandemic, the continuation of decentralized trials offers many continued benefits to clinical trial efficiency and patient-centricity. Thus, we believe that decentralized clinical trials are here to stay. Planning a decentralized clinical trial brings with it new challenges to overcome. We understand it is not easy to adapt to new ways of designing and running clinical trials.

Learn from Veristat’s team of scientific- minded experts to help you navigate this novel approach designed with a custom virtual ecosystem to satisfy both study needs and patient needs.

VIEW THE INFOGRAPHIC!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene